七宮蓮 (Ren Nanamiya) - マイポータル

基本情報

所属: 東北大学大学院医学系研究科抗体創薬研究分野

J-GLOBAL ID: 202101010517474800

研究分野

ライフサイエンス / 腫瘍生物学 /

学歴

論文

An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.

Tomohiro Tanaka, Tomokazu Ohishi, Teizo Asano, Junko Takei, Ren Nanamiya, Hideki Hosono, Masato Sano, Hiroyuki Harada, Manabu Kawada, Mika K Kaneko, Yukinari Kato

Oncology reports 46(1) 2021年7月査読有り
Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin.

Tomohiro Tanaka, Teizo Asano, Masato Sano, Junko Takei, Hideki Hosono, Ren Nanamiya, Takuro Nakamura, Miyuki Yanaka, Hiroyuki Harada, Masato Fukui, Hiroyoshi Suzuki, Kazuyuki Uchida, Takayuki Nakagawa, Yukinari Kato, Mika K Kaneko

Monoclonal antibodies in immunodiagnosis and immunotherapy 2021年5月26日査読有り
Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry.

Teizo Asano, Ren Nanamiya, Junko Takei, Takuro Nakamura, Miyuki Yanaka, Hideki Hosono, Tomohiro Tanaka, Masato Sano, Mika K Kaneko, Yukinari Kato

Monoclonal antibodies in immunodiagnosis and immunotherapy 2021年4月20日査読有り
Development of Antihuman Killer Cell Lectin-Like Receptor Subfamily G Member 1 Monoclonal Antibodies for Flow Cytometry.

Teizo Asano, Ren Nanamiya, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato

Monoclonal antibodies in immunodiagnosis and immunotherapy 40(2) 76 - 80 2021年4月査読有り
Development of Anti-human T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry.

Junko Takei, Teizo Asano, Ren Nanamiya, Takuro Nakamura, Miyuki Yanaka, Hideki Hosono, Tomohiro Tanaka, Masato Sano, Mika K Kaneko, Hiroyuki Harada, Yukinari Kato

Monoclonal antibodies in immunodiagnosis and immunotherapy 40(2) 71 - 75 2021年4月査読有り
Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry.

Tomohiro Tanaka, Ren Nanamiya, Junko Takei, Takuro Nakamura, Miyuki Yanaka, Hideki Hosono, Masato Sano, Teizo Asano, Mika K Kaneko, Yukinari Kato

Monoclonal antibodies in immunodiagnosis and immunotherapy 40(2) 65 - 70 2021年4月査読有り
11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.

Ryoko Saito, Yasuhiro Miki, Takuto Abe, Eisaku Miyauchi, Jiro Abe, Ren Nanamiya, Chihiro Inoue, Ikuro Sato, Hironobu Sasano

British journal of cancer 123(1) 61 - 71 2020年7月査読有り
The correlation of p22phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma.

Masayuki Kobayashi, Ryoko Saito, Yasuhiro Miki, Ren Nanamiya, Chihiro Inoue, Jiro Abe, Ikuro Sato, Yoshinori Okada, Hironobu Sasano

Oncotarget 10(10) 1119 - 1131 2019年2月1日査読有り

MISC

ヒト肺癌における腫瘍内Glucocorticoid産生が腫瘍内免疫微小環境に与える影響

齊藤涼子, 三木康宏, 井上千裕, 七宮蓮, 阿部二郎, 佐藤郁郎, 笹野公伸

日本病理学会会誌 108(1) 2019年
OsimertinibのEGFR非依存的な抗腫瘍効果に関する検討

七宮蓮, 七宮蓮, 齊藤涼子, 小林雅行, 三木康宏, 三木康宏, 井上千裕, 笹野公伸

日本病理学会会誌 108(1) 2019年
EphB4-cellcycle pathwayを介したOsimertinibのEGFR非依存的な抗腫瘍効果に関する検討

七宮蓮, 齊藤涼子, 三木康宏, 井上千裕, 笹野公伸

日本癌学会学術総会抄録集(Web) 78th 2019年

講演・口頭発表等

Development of anti-CCR9 monoclonal antibodies using a Cell- Based Immunization and Screening (CBIS) method

Ren Nanamiya, Mika K. Kaneko, Yukinari Kato

日本生化学会東北支部第87 回例会・シンポジウム 2021年5月29日